Exactly. And most of us were worried about a rejection of the manufacturing process. That did not happen.
Even though the FDA wants clarity on potency measurements this is not their major concern.
There is good reason to expect an accelerated approval with a post-approval condition for an additional study.
- Forums
- ASX - By Stock
- MSB
- Next steps discussion
Next steps discussion, page-9
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 37637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | 1.015 |
8 | 195410 | 1.010 |
5 | 95607 | 1.005 |
7 | 208096 | 1.000 |
3 | 103747 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 37637 | 1 |
1.030 | 29757 | 2 |
1.035 | 91225 | 3 |
1.040 | 72457 | 5 |
1.045 | 126212 | 4 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online